Hematopoietic stem cell transplantation and gut microbiota: outcomes and use of probiotics, a narrative review

Authors

  • Jéssica Härter UFRGS
  • Lucia Mariano da Rocha Silla Universidade Federal do Rio Grande do Sul/Hospital de Clínicas de Porto Alegre

DOI:

https://doi.org/10.46765/2675-374X.2022v3n2p175

Keywords:

Hematopoietic stem cell transplantation, Microbiota, Gut microbiota, Probiotics

Abstract

Hematopoietic stem cell transplantation (HSCT) is a complex procedure used to treat several onco-hematological neoplasms, benign hematological diseases, and some types of solid tumors. In recent years, the role of the gut microbiota in HSCT has been studied, revealing that the microbiota has a direct interaction with the immune system and the microbial balance within the body (eubiosis), providing beneficial health effects, and changes in such state result in dysbiosis, which has been associated with several pathological states. The process in which the patient undergoes HSCT can cause microbiota imbalance with reduced diversity, which would be related to negative post-HSCT outcomes, including increased mortality and development of graft-versus-host disease (GVHD). The modulation of the gut microbiota through methods such as the use of probiotics has been explored as an alternative for the recovery and/or maintenance of the gut microbiota.

Downloads

Published

11/23/2022

How to Cite

Härter, J., & Mariano da Rocha Silla, L. (2022). Hematopoietic stem cell transplantation and gut microbiota: outcomes and use of probiotics, a narrative review. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 3(2), 175. https://doi.org/10.46765/2675-374X.2022v3n2p175

Most read articles by the same author(s)